Immunophotonics’ Tomas Hode, PhD (CIO and President) is attending Spectrum Conference, January 16 – 18, in Miami, Florida. Some of...

Our networking is well underway with investors and potential strategic partners for JPM2025 in San Francisco, January 13 – 16,...

Lu Alleruzzo, CEO and David Anderson, PhD, CSO of Immunophotonics, are excited to participate in the NCI SBIR Peer Learning...

Immunophotonics co-founders Lu Alleruzzo, CEO and Tomas Hode, PhD, CIO, and President will attend the AngioDynamics International Life Symposium taking...

Congratulations to Professor Wei Chen and his lab University of Oklahoma for their publication titled “Localized ablative immunotherapy enhances antitumor...

Siu Kit “Samuel” Lam, PhD, Senior Vice President of Science & Research at Immunophotonics, Inc. attended the SITC Immuno-Oncology Drug...

Immunophotonics wants to congratulate Professor Wei Chen and his lab University of Oklahoma, along with contributors Lu Alleruzzo, Samuel S.K....

Immunophotonics is pioneering the field of Interventional Immunology-Oncology™, where a single injection of IP-001 --seamlessly integrated into the clinical workflow--...

Immunophotonics co-founders Lu Alleruzzo (CEO), Tomas Hode, PhD (CIO and President), and David Anderson, PhD (CSO) are excited to be...

Immunophotonics won the Startup World Cup St. Louis Regional finals. A big thank you to Emily Hemingway and her team...